Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.849
-0.014 (-1.59%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Vivos Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 11 | 18 | 25 | 15 | 9 | 52 | |
| Market Cap Growth | -16.52% | -27.79% | 69.64% | 61.00% | -82.13% | -50.41% | |
| Enterprise Value | 23 | 28 | 21 | 16 | 5 | 25 | |
| Last Close Price | 0.85 | 2.03 | 4.29 | 12.44 | 10.05 | 56.25 | |
| PS Ratio | 0.66 | 1.05 | 1.68 | 1.08 | 0.58 | 3.07 | |
| PB Ratio | - | -11.77 | 3.18 | 36.24 | 1.93 | 2.03 | |
| P/TBV Ratio | - | - | 5.37 | - | 5.59 | 2.32 | |
| EV/Sales Ratio | 1.31 | 1.59 | 1.37 | 1.16 | 0.34 | 1.45 | |
| Debt / Equity Ratio | -8.71 | -8.71 | 0.19 | 4.85 | 0.50 | 0.05 | |
| Net Debt / Equity Ratio | -7.40 | -7.40 | -0.60 | 0.86 | -0.23 | -0.89 | |
| Net Debt / EBITDA Ratio | -0.62 | -0.62 | 0.45 | -0.02 | 0.05 | 1.22 | |
| Net Debt / FCF Ratio | -0.65 | -0.65 | 0.36 | -0.03 | 0.05 | 1.26 | |
| Asset Turnover | 0.86 | 0.86 | 1.16 | 1.13 | 0.68 | 0.57 | |
| Quick Ratio | 0.20 | 0.20 | 1.34 | 0.25 | 0.58 | 3.43 | |
| Current Ratio | 0.24 | 0.24 | 1.50 | 0.34 | 0.80 | 3.64 | |
| Return on Equity (ROE) | -663.02% | -663.02% | -266.25% | -521.22% | -157.19% | -92.31% | |
| Return on Assets (ROA) | -61.50% | -61.50% | -53.68% | -88.42% | -66.00% | -41.24% | |
| Return on Capital Employed (ROCE) | -281.10% | -281.10% | -108.40% | -502.60% | -362.40% | -74.40% | |
| Earnings Yield | -184.81% | -116.03% | -44.07% | -91.20% | -257.76% | -39.18% | |
| FCF Yield | -153.68% | -96.48% | -52.48% | -85.93% | -221.72% | -35.02% | |
| Buyback Yield / Dilution | -104.66% | -104.66% | -311.68% | -32.46% | -8.39% | -65.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.